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Abstract 
Accurate information on drug use in communities is essential if health, social and 
economic harms associated with illicit drug use are to be addressed efficiently. In 
most countries population drug use is estimated indirectly via surveys, medical 
presentations and police and custom seizures. All of these methods have at least some 
problems due to bias, small samples and/or long time delays between collecting the 
information and analysing the results. Recently the direct quantification of drug 
residues in wastewater has shown promise as a means of monitoring drug use in 
defined geographical areas. In this study we measured 
3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and 
benzoylecgonine in sewage inflows in metropolitan and regional areas of Australia 
and compared these data with published European data. Cocaine use was small 
compared to European cities (p < 0.001) but was compensated for by much greater 




more popular in regional areas (p < 0.05) whereas methamphetamine and cocaine 
were mainly consumed in the city (p < 0.05). Greater than 5-fold increases in MDMA 
use were detected on weekends (p < 0.001). This approach has the potential to 
improve our understanding of drug use in populations and should be further 
developed to improve prevention and treatment programs. 
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Accurate information on drug use in communities is essential if health, social and 
economic harms associated with illicit drug use are to be addressed efficiently. In 
most countries population drug use is estimated indirectly via surveys, medical 
presentations and police and customs seizures. All of these methods have at least 
some problems due to bias, small samples and/or long time delays between collecting 
the information and analysing the results. Surveys are also very costly, limiting their 
use, and are unable to provide sufficient resolution in small regional population areas. 
There are several important consequences of these limitations in current methods. One 
such consequence is that direct measurement of changes in drug use as a result of a 
public health campaigns is difficult. A relatively inexpensive method that could 
provide near real-time measures would be needed for such evaluation. A second 
consequence is that international comparisons between countries based on 
self-reported drug use (e.g. World Drug Report 2009) are limited. Differences in 
questions, survey methods, etc. limit comparability. International comparisons have 
important ramifications for the implementation and development of global strategies 
to combat illicit drug use, and a more accurate method of comparison would be of 
value. 
Recently, the measurement of illicit drugs in wastewater as a means of direct and 
quick assessment of drug use in a community has been explored in a number of 
countries [1]. The advantages of developing this technology to improve information 
on illicit drug use have been recognised [2, 3]. The first reported study was conducted 
in Italy and sampled from the River Po as well as four wastewater treatment plants 
servicing medium-sized Italian cities [4]. Data showed that benzoylecgonine, the 
major human metabolite of cocaine, was present in the samples. Subsequent studies 
by this group and others have extended these findings to a number of different 




of additional illicit drugs including methamphetamine, heroin and cannabis have also 
now been assessed [6-8]. Calculations of per capita drug consumption have then been 
made based on populations served by the wastewater treatment plant, daily volumes 
of wastewater produced in the areas, and excretion rate of each drug. Although there 
are a number of technical issues outstanding for drugs with unstable metabolites, it is 
clear that this approach provides an identifiable method to objectively quantitate illicit 
drug use on a continual basis. 
Traditionally, information on population drug use in Australia is mainly obtained 
from a project named National Drug Strategy Household Survey (NDSHS), which is 
carried out by the government once every three years [9]. The reports derived from 
the survey are very informative, but limited data on weekly fluctuation and 
geographic difference of the drug use is provided, also up-to-date information is 
unavailable. It is also reported that the use pattern of illicit stimulants in Oceania 
differs from Europe, with methamphetamine and 
3,4-methylenedioxymethamphetamine (MDMA) more popular in Australia and 
cocaine users equally distributed in these two continents [10]. However, these 
differences are based on survey, seizure and anecdotal evidence, and we hypothesised 
that wastewater analysis data of Australia and Europe would provide a more objective 
comparison. 
Hence, in this study we applied this novel approach to wastewater samples collected 
in the State of South Australia from a number of metropolitan and regional 
wastewater treatment plants on midweek and weekend days, confined our analysis to 
the stimulant drugs (methamphetamine, MDMA and cocaine), and then compared our 
results with previously published data from Europe.  
2. Materials and methods 




From April 2009 to October 2009, 1.2-L samples were taken from sewage inlet pipes 
of metropolitan and regional wastewater treatment plants immediately after sewage 
has passed through screens during which large solids were removed. The metropolitan 
samples were obtained from three independent plants servicing the Adelaide greater 
metropolitan area using auto-samplers which collected 24-hour composite samples 
flow-dependently.  Regional samples were grabbed from 10 regional plants 
throughout the State of South Australia and ranged in the populations they serviced 
from 370 to 23,300 (Table 1). No more than one sample was collected from one plant 
in 1 day. The samples were stored frozen until analysis.  
2.2. Drug analysis 
Samples were thawed to room temperature and mixed by inverting several times, and 
then filtered under vacuum using glass microfiber filters GF/A 1.6μm (Whatman, 
Kent, U.K.). 200μL of deuterated internal standards of MDMA, methamphetamine 
and benzoylecgonine were added to 300mL of duplicate samples to give resultant 
concentrations of 33.3, 33.3 and 166.7ng/L, respectively. Acetic acid (2.5%) was 
added to lower the pH of the samples to 4.5 - 5. The acidified samples were loaded 
onto pre-conditioned mixed-mode solid phase extraction (SPE) cartridges (UCT™ 
XRDAH; 500mg/6mL). Cartridges were successively washed with 6mL of pH 5.7 
acetate buffer, 2mL of 0.1M acetic acid and 6mL of methanol.  Analytes were eluted 
with a mixture of 96% dichloromethane: i-propanol (80:20) / 4% ammonia and 
evaporated to dryness. The dry residue was reconstituted with 20μL of methanol and 
then mixed with 180μL of 0.1% formic acid. A set of diluted extracts was prepared by 
transferring 40μL of the original extract to new vials and diluting each with 160μL of 
0.1% formic acid. Both sets were analysed by liquid chromatography / tandem mass 
spectrometry (LC/MS/MS).  
Chromatographic separation was carried out using an Agilent 1200 series liquid 




connected to a PFP guard column (5μm, 4mm × 2.0mm). The mobile phase consists 
of methanol (solvent A) and 0.1% formic acid (solvent B) with a flow rate of 
0.5mL/min. The gradient started with 95% B for 1 min. Then it was brought down to 
5% B in the next 14 min and kept there for 1 min. Finally, the gradient was brought 
back to 95% B in 0.1 min and kept there for 2 min. Sample injection volume was 
10μL. Mass spectra were obtained using a 4000 Q-TrapTM (Applied Biosystems, 
Toronto, Canada) system equipped with an electrospray ionisation source. Mass 
spectrometric analysis was performed in positive mode via multiple-reaction 
monitoring (MRM). The optimum MS/MS parameters for the detection of our 
analytes were as follows: nitrogen was used as the nebulizer and auxiliary gas, the ion 
spray voltage (IS) was maintained at 4.0kV and the source temperature (TEM) was 
650°C, the curtain gas (CUR), gas 1 (GS1), gas 2 (GS2) and collision gas (CAS) were 
set at 30, 70, 70 and ‘medium’, respectively. Three transitions were used for each 
analyte and the most responsive one was used for quantitation. The most responsive 
transition of each internal standard was also monitored for quantitation. Settings for 
compound-dependent parameters are summarised in Table 2.  
2.3. Validation 
The limits of quantitation (LOQ) were established as the concentration of the analytes 
in distilled water that gives rise to peak height with an S/N of 10. They were set at 
2ng/L for methamphetamine and MDMA, and 10ng/L for benzoylecgonine. Using the 
above LC/MS/MS conditions, methamphetamine and MDMA were linear up to 
500ng/L, and benzoylecgonine to 2500ng/L (r2 > 0.998 for all analytes). The absolute 
recovery of the extraction method for MDMA, methamphetamine and 
benzoylecgonine were found to be 86.5 -92.0%, 80.5 -85.7%, and 53.7 -61.2%, 
respectively. Using internal standards, the relative recovery was 97.9 -102.1% for 
MDMA, 97.6 -102.4% for methamphetamine and 98.8 -101.2% for benzoylecgonine. 




10 times on each of 2 days. The RSD% was found to be 3.66% for MDMA, 1.07% for 
methamphetamine, and 4.08% for benzoylecgonine, respectively. 
2.4. Data analysis 
The concentrations of methamphetamine and MDMA were calculated by multiplying 
the concentration of spiked internal standard by the ratio of analyte peak area to 
internal standard peak area of the diluted set. The most responsive transitions were 
used for quantitation, and the other transitions were used for identification of the 
analytes (see Table 2). The concentration of benzoylecgonine was determined in the 
same way using the undiluted set.  
Drug consumption estimation was based on the recent reported method [11], in which 
drug excretion per 1000 of the population was calculated from the known 
concentration of drug measured in sewage, daily flow of sewage to the wastewater 
treatment plant and population served by the plant. 
For temporal comparison, only data from metropolitan samples were used. 
Considering a 24-hour composite sample is a mixture of samples collected 
flow-dependently from 8:00 am of the day before sample collection day to 8:00 am of 
the sample collection day, the metropolitan samples collected on Tuesday, 
Wednesday or Thursday were grouped as mid-week samples, and those collected on 
Saturday, Sunday or Monday were grouped as weekend samples.  
Similarly, geographic comparison was based on metropolitan samples collected on 
Wednesdays and regional samples grabbed on Tuesday, considering the fact that the 
Wednesday composite samples were collected from Tuesday morning to Wednesday 
morning. 
All samples collected from metropolitan plants were used for international 
comparisons. Data were analysed using the following procedure: first, average daily 




estimated; then daily disposition on each day of the week in Adelaide was calculated 
as the average of the three plants; finally, daily excretion of the drug residues in 
Adelaide was expressed as the average of seven days. The final data were then used 
for comparison with published data in European cities.  
Data were analysed by GraphPad PrismTM software. Means and standard error of the 
means were calculated. One-way ANOVA with Tukey’s post hoc tests or unpaired 
two-tailed t-tests were applied as appropriate. 
3. Results 
MDMA, methamphetamine and benzoylecgonine were detected in all of the samples 
taken from metropolitan plants (Fig. 1).  When samples collected midweek were 
compared to weekend collections, higher concentrations of stimulants in weekend 
samples were observed (p < 0.05). In particular, weekend use of MDMA was five 
times higher than mid-week use (p < 0.001).  
A direct comparison of drug amount between metropolitan and regional samples 
demonstrated geographical differences (Fig. 2). MDMA use in regional areas was 
twice as high (p < 0.05) as in Adelaide. In contrast, methamphetamine use was higher 
in metropolitan areas (p < 0.05). Only low concentrations of cocaine metabolite were 
detected in regional samples whereas it was easily found in samples from the city (p < 
0.001). 
Table 3 shows a comparison of the three analytes of interest reported in the literature 
and compared with the values measured in this study.  Our data was calculated as 
per the previous paper of Zuccato et al [11] to directly compare with the previous 
published results. Very large differences were observed. Cocaine use is approximately 
30 times greater in Milan and London compared to Adelaide (p < 0.001), but the latter 
city has a 10-fold higher use of MDMA (p < 0.05) and a 30-fold higher use of 





Our analysis of wastewater has consistently detected illicit stimulant drugs and shown 
geographical as well as time of the week differences in drug concentrations. We have 
no way of identifying if these differences are due to the number of drug users or the 
daily dose consumed or a combination of both. This would require some adjunct 
survey data. However, data derived from wastewater analysis with the unit mg/d/1000 
people may be regarded as a unique indicator related to drug prevalence that is 
comparable among different situations [2]. 
The results suggest that weekend use of drugs was more than midweek use. This 
change is similar to those reported by other authors. Zuccato et al [11] showed 
increased concentrations of cocaine and MDMA on the weekend wastewater samples 
in Italy. van Nuijs et al [12] found higher concentration of cocaine and its metabolites 
in Belgian weekend samples. Cocaine and MDMA consumption on weekends and 
during a music festival were higher than weekdays in France [13]. Occurrence of 
methamphetamines, MDMA as well as cocaine and its metabolites showed an 
increase on weekends in Spain [14, 15]. Benzoylecgonine and MDMA concentrations 
were higher in weekend samples in the study carried out in Croatia [16]. Estimated 
consumption of cocaine and amphetamines is also higher on weekends in Canadian 
cities [5].  
This study found that cocaine was more popular in urbanised areas, which agreed with 
the studies in Europe [12, 13, 17] and North America  [5] [18]. However, the 
influence of urbanity on MDMA and methamphetamine use was complicated. Our 
results showed more MDMA use in regional areas and higher prevalence of 
methamphetamine use in urban areas, while the study carried out in the US found 
higher MDMA use in urban centres and no geographic difference of 
methamphetamine prevalence. Metcalfe et al. analysed wastewater samples from 




in the biggest one [5], while Postigo et al.  reported that the highest prevalence of 
MDMA and methamphetamine were found in one of the smallest urban area 
investigated in Spain [17]. 
In this article we compared stimulant use in Australia with that in UK and Italy, 
though wastewater epidemiological studies were also carried out in other European 
countries such as France [13], Spain [17], Germany [19], Belgium [12], Switzerland 
[11] and Croatia [16]. Detailed drug profiles were different from country to country, 
but the levels were of the same order in western European countries, with the 
exception that cocaine use in Croatia was several times lower [16].  Our study has 
shown large difference in stimulant use between Australia and the European countries. 
This finding agrees with the World Drug Report data [10] showing higher use of 
MDMA and methamphetamine in Australia compared to all other countries surveyed.  
However, the present study showed that methamphetamine and MDMA prevalence in 
Australia were approximately 10-40 times higher than European countries, which was 
much greater than expected from international survey data [10]. Besides, the World 
Drug Report suggested that the proportion of cocaine users was similar in Europe and 
Oceania [10], while the wastewater analysis data showed that in Europe the 
prevalence of cocaine use might be approximately thirty times higher than Australia. 
van Nuijs et al [12] calculated cocaine consumption in Belgium and by extrapolation 
estimated that the prevalence of cocaine users in Belgium was 0.8%, which agreed 
with the data provided by the United Nations Office on Drugs and Crime [20]. 
According to a study carried out by Postigo et al [17] in Spain, the order of drug 
abundance in wastewater was slightly different from the official profile. The 
observations of Zuccato et al [4] for benzoylecgonine in Italian wastewater indicated 
that use of cocaine was about 40,000 doses per day, which was much higher than 
officially estimated.  The procedures used in these wastewater epidemiology studies 




showed large differences. One possible reason is the bias inherent in self-report 
surveys since they were nation-dependent in design and protocol. 
It would be ideal if all the samples analysed in this study were composite samples 
collected flow-dependently for 24 hours. However, since the auto samplers were not 
available in regional wastewater treatment plants, only grab samples could be 
obtained from these sources. Thus, comparison between drug use in metropolitan and 
regional area were based on comparison of composite and grab samples. Little is 
known about the difference between a composite and a grab sample from a regional 
plant, hence whether the grab samples could represent actual drug use in these 
regional areas or not were uncertain. One possible solution to this issue so far would 
be increasing the sample size to minimize the random error, which was what we tried 
to do in this study. 
The issue of the analytes of interest being the result of non-illicit drug use was 
considered. Selegiline, a prescription drug, is used in the treatment of Parkinson's 
disease. Approximately 37% of oral administered selegiline is excreted as 
l-methamphetamine in the urine [21]. This amount of l-methamphetamine from 
selegiline use may contribute to the methamphetamine concentration in the 
wastewater because the current LC/MS/MS method was not able to differentiate 
l-methamphetamine from its isomer, the illicitly used d-methamphetamine. However, 
it was estimated that from 2006 to 2008, for every 1000 people in Australia about 
0.5mg of selegiline was consumed daily [22]. Hence, selegiline use only causes about 
0.5 × 37% = 0.185 mg/d/1000 people of methamphetamine excretion in the 
community, which is far below the level of methamphetamine detected in this study. 
Use of famprofazone (an analgesic and antipyretic agent) and benzphetamine (an 
anorectic agent) may also result in excretion of methamphetamine [23, 24], but these 
two medications are not prescribed in Australia. Hence, the methamphetamine 




pharmaceutical drug is metabolised to MDMA or benzoylecgonine, hence the only 
source of these residues in wastewater is the illicit use of MDMA and cocaine. 
In this study only the use of cocaine, MDMA and methamphetamine were monitored. 
However, we are currently fine-tuning our analysis procedures in order to determine a 
larger range of illicit drug residues and utilize this method to observe other illicit drug 
use in Australia. Also, it should be noted that our results were only from one state and 
may not accurately reflect Australia’s drug use as a whole. Expanding the sampling 
sites to other states of Australia to get a full picture of Australian drug use is planned. 
Moreover, some technical issues that we are examining may improve the reliability of 
the estimates. These include degradation of analytes in wastewater and employing a 
population biomarkers to normalize the drug concentrations for a measured 
population [25]. 
This study shows the utility of analytical chemistry in the field of drug use monitoring. 
Zuo et al. also demonstrated another novel way to monitor drug use, in which GC-MS 
was employed to detect cocaine on US paper currency [26]. These studies together 
with other similar ones indicated that development of methods based on modern 
analytical chemistry could be a new trend in drug use monitoring. 
This study estimated the stimulant use in Australia using wastewater epidemiology 
and compared the data with the other recent studies in Europe. This report along with 
the others indicates that wastewater analysis can be used to identify geographic and 
temporal changes in drug use in urban and regional communities. The method 
provides objective and timely data that cannot be gleaned from traditional 
epidemiological methods. Therefore, it has great potential application in objectively 
measuring outcomes when time- and area- specific campaigns are to be planned and 
evaluated by police and health care agencies. Continued development of this approach 
to achieve a standardised method for a range of drugs which could be applied globally 
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Table 1  
Concentration of MDMA, methamphetamine and benzoylecgonine in wastewater samples collected from metropolitan and regional treatment plants in South Australia.  
 
Plant 











Concentration of residues (ng/L) (mean ± SEM or single value) 

























Sun 2* Δ 208 ± 124 346 ± 75 55 ± 8 
Mon 2* Δ 265 ± 138 4108 ± 1118 52 ± 8 
Tue 3* Δ 39 ± 20 216 ± 35 27 ± 8 
Wed  4*# Δ 26 ± 8 224 ± 17 30 ± 7 
Thu 1* Δ 63 287 31 
Fri 1 Δ 72 338 40 
Sat 2* Δ 85 ± 51 311 ± 103 50 ± 14 
Christies 
Beach 27520 150000 
Sun 2* Δ 706 ± 264 640 ± 116 74 ± 1 
Mon 1* Δ 321 445 35 
Tue 3* Δ 76 ± 26 388 ± 116 31 ± 14 
Wed 4*# Δ 62 ± 21 367 ± 45 17 ± 8 
Fri 1 Δ 192 527 30 
Sat 2* Δ 330 ± 81 553 ± 12 58 ± 1 
Glenelg 52550 200000 
Sun 1* Δ 326 357 118 
Mon 4* Δ 209 ± 83 368 ± 67 64 ± 13 
Tue 3* Δ 66 ± 12 277 ± 18 38 ± 4 
Wed 3*# Δ 51 ± 23 368 ± 58 47 ± 5 
Thu 1* Δ 114 524 67 
Fri 1 Δ 136 505 69 
















Tue 2# 20 ± 19 69 ± 30 ND 
Finger Point 5226 23300 Tue 2# 183 ± 16 160 ± 31 ND 
Mt. Burr 121 370 Tue 2# 5 ± 3 12 ± 0 12 ± 0 
Nangwarry 134 480 Tue 1# ND 305 ND 
Naracoote 900 4780 Tue 1# ND 2 ND 
Pt. Augusta East 1323 5000 Tue 1# 167 218 ND 
Pt. Augusta West 627 3500 Tue 1# 200 507 ND 
Pt. Lincoln 2842 12660 Tue 4# 268 ± 50 105 ± 36 14 ± 4 
Pt. Pirie 3414 13260 Tue 2# 31 ± 20 85 ± 47 ND 






ND: Not detected.  
Δ Samples used for international comparisons.  
* Samples used for comparisons of midweek days and weekend days.  
# Samples used for comparisons of metropolitan and regional areas.  
18 
Table 2  
Selected mass spectrometric parameters used in the analysis of 3,4-methylenedioxymethamphetamine 

















MDMA 1# 194 163 60 50 10 20 30 
MDMA 2 194 105 40 50 10 30 30 
MDMA 3 194 135 40 50 10 35 30 
MDMA-d5*# 199 165 60 50 10 20 30 
Methamphetamine 1# 150 91 60 50 10 25 12 
Methamphetamine 2 150 119 40 50 10 25 12 
Methamphetamine 3 150 65 40 50 10 44 12 
Methamphetamine-d5*# 155 92 60 50 10 25 12 
Benzoylecgonine 1# 290 168 120 130 10 30 15 
Benzoylecgonine 2 290 105 80 130 10 45 15 
Benzoylecgonine 3 290 77 80 130 10 80 15 
Benzoylecgonine-d3*# 293 171 120 130 10 30 15 
a Declustering potential.  
b Entrance potential.  
c Collision energy.  
d Collision cell exit potential. 
# Transitions used for quantitation.  











A comparison of amount of analytes detected in wastewater inflows. 
  Adelaide Milan # London # 
MDMA 39.3 ± 7.7 4.2 ± 0.1** 3.4 ± 0.5* 
Methamphetamine 85.1 ± 7.2 4.5 ± 0.4*** 2.4 ± 0.2*** 





Data expressed as mg/day/1000 people, mean ± SEM. Adelaide: n = 20. Milan: n = 21 for 
Benzoylecgonine, 14 for MDMA and methamphetamine. London: n = 4. # Data derived from Zuccato 
et al [11].  
*p < 0.05 (1-way ANOVA with Tukey’s post hoc test). 
** p < 0.01 (1-way ANOVA with Tukey’s post hoc test). 




A comparison of amount of analytes detected in sewage inflows collected midweek 
and at the weekend expressed as mg/day/1000 people, mean ± SEM. *p < 0.05, **p < 
0.01 and ***p < 0.001 two-tailed t-test; n = 20. Meth = methamphetamine and BE = 
benzoylecgonine. 
Fig. 2. 
A comparison of amount of analytes detected in sewage inflows collected in 
metropolicatn and regional centers expressed as mg/day/1000 people, mean ± SEM. 
*p < 0.05 and ***p < 0.001 two-tailed t-test; n = 10. Meth = methamphetamine and 




























A comparison of amount of analytes detected in sewage inflows collected midweek 
and at the weekend expressed as mg/day/1000 people, mean ± SEM. *p < 0.05, **p < 





























A comparison of amount of analytes detected in sewage inflows collected in 
metropolicatn and regional centers expressed as mg/day/1000 people, mean ± SEM. 
*p < 0.05 and ***p < 0.001 two-tailed t-test; n = 10. Meth = methamphetamine and 
BE = benzoylecgonine. 
 
 
